๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—† A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals โ—† The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 โ—† Funding the Future: Inside the โ‚ฌ75k Women TechEU and ยฃ10M Createch Grants for Startups and SMEs โ—† FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings โ—† Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions โ—† The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs โ—† Addiction Counsellors of Ireland Launch Strategic Plan 2026โ€“2029 to Prepare for CORU Regulation โ—† Ireland Funds โ‚ฌ426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand โ—†
Markets ยท 15 min delay
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
ISEQ9,241.3โ–ฒ +0.62%
NBI4,187.6โ–ฒ +1.14%
PFE28.42โ–ผ -0.38%
AZN74.18โ–ฒ +0.81%
NVO103.55โ–ฒ +2.07%
ROG261.40โ–ผ -0.55%
ABBV174.92โ–ฒ +0.29%
EUR/USD1.0842โ–ผ -0.12%
Updated 04 Jul 2026 ยท HPRA open data

Irish Medicines Database

Every medicine authorised for the Irish market โ€” 10,165 products with active substances, licence holders, dosage forms and prescription status.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
468 medicines starting with โ€œNโ€
MedicineActive substanceLicence holderStatus
NeoRecormon 4000 IU Solution for injection
EU/1/97/031/041
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 4000 IU Solution for injection
EU/1/97/031/042
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 500 IU Solution for injection
EU/1/97/031/025
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 500 IU Solution for injection
EU/1/97/031/026
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 5000 IU Solution for injection
EU/1/97/031/033
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 5000 IU Solution for injection
EU/1/97/031/034
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 6000 IU Solution for injection
EU/1/97/031/043
Epoetin beta Roche Registration GmbH โ€”
NeoRecormon 6000 IU Solution for injection
EU/1/97/031/044
Epoetin beta Roche Registration GmbH โ€”
Neotigason 10 mg capsules
PA1986/113/001
Acitretin Teva B.V. Marketed
Neotigason 10 mg capsules
PPA1463/238/001
Acitretin IMED Healthcare Ltd., โ€”
Neotigason 25 mg capsules
PA1986/113/002
Acitretin Teva B.V. Marketed
Neotigason 25 mg capsules
PPA2306/020/001
Acitretin Originalis B.V. โ€”
Neparvis 15 mg/16 mg granules in capsules for opening
EU/1/16/1103/019
Sacubitril, Valsartan Novartis Europharm Limited โ€”
Neparvis 24 mg/26 mg film-coated tablets
EU/1/16/1103/001
Sacubitril valsartan Novartis Europharm Limited โ€”
Neparvis 49 mg/51 mg film-coated tablets
EU/1/16/1103/002-004
Sacubitril valsartan Novartis Europharm Limited โ€”
Neparvis 6 mg/6 mg granules in capsules for opening
EU/1/16/1103/018
Sacubitril, Valsartan Novartis Europharm Limited โ€”
Neparvis 97 mg/103 mg film-coated tablets
EU/1/16/1103/005-007
Sacubitril valsartan Novartis Europharm Limited โ€”
Nepexto 25 mg solution for injection in pre-filled syringe
EU/1/20/1436/001-002
Etanercept Biosimilar Collaborations Ireland Limited โ€”
Nepexto 50 mg solution for injection in pre-filled pen
EU/1/20/1436/005-006
Etanercept Biosimilar Collaborations Ireland Limited โ€”
Nepexto 50 mg solution for injection in pre-filled syringe
EU/1/20/1436/003-004
Etanercept Biosimilar Collaborations Ireland Limited โ€”
Nerlynx 40 mg Film-coated tablet
EU/1/18/1311/001
Neratinib Pierre Fabre Medicament โ€”
Neulasta 6 mg solution for injection
EU/1/02/227/001-002
Pegfilgrastim Amgen Europe B.V., โ€”
Neupogen 30 MU (0.3 mg/ml) Solution for injection filgrastim
PA1026/001/001
Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 30 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/007
Filgrastim Amgen Europe B.V., Marketed
Neupogen Singleject 48 MU/0.5 ml Solution for injection in a pre-filled syringe filgrastim
PA1026/001/008
Filgrastim Amgen Europe B.V., Marketed
Neupro
EU/1/05/331/10-12,32-37
Rotigotine Schwarz Pharma Limited โ€”
Neupro
EU/1/05/331/1-3,14-20
Rotigotine UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/38-46
Rotigotine UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/4-6,21-25
Rotigotine Schwarz Pharma Limited โ€”
Neupro
EU/1/05/331/47-55
Rotigotine UCB Pharma S.A. โ€”
Neupro
EU/1/05/331/7-9,26-31
Rotigotine Schwarz Pharma Limited โ€”
Neuraceq 300 MBq/mL solution for injection
EU/1/13/906/001
Florbetaben Life Molecular Imaging GmbH โ€”
Neurontin 100 mg hard capsules
PA23355/051/001
Gabapentin Viatris Healthcare Limited Marketed
Neurontin 300 mg hard capsules
PA23355/051/002
Gabapentin Viatris Healthcare Limited Marketed
Neurontin 400 mg hard capsules
PA23355/051/003
Gabapentin Viatris Healthcare Limited Marketed
Neurontin 600 mg film-coated tablets
PA23355/051/004
Gabapentin Viatris Healthcare Limited Marketed
Neurontin 800 mg film-coated tablets
PA23355/051/005
Gabapentin Viatris Healthcare Limited Marketed
Neurostil 100 mg capsules, hard
PA0749/164/001
Gabapentin Teva Pharma B.V. Not marketed
Neurostil 100 mg hard capsules
PA1986/128/001
Gabapentin Teva B.V. Not marketed
Neurostil 300 mg capsules, hard
PA0749/164/002
Gabapentin Teva Pharma B.V. Not marketed
Neurostil 300 mg hard capsules
PA1986/128/002
Gabapentin Teva B.V. Not marketed
Neurostil 400 mg capsules, hard
PA0749/164/003
Gabapentin Teva Pharma B.V. Not marketed
Neurostil 400 mg hard capsules
PA1986/128/003
Gabapentin Teva B.V. Not marketed
Neutrogena T/Gel Shampoo 5 mg/ml
PA23490/001/001
Coal tar JNTL Consumer Health I (Ireland) Limited Not marketed
Nevanac 1 mg/ml Eye drops, suspension
EU/1/07/433/001
Nepafenac Novartis Europharm Limited โ€”
Nevanac 3 mg/ml Eye drops, suspension
EU/1/07/433/002
Nepafenac Novartis Europharm Limited โ€”
Nexavar 200 mg film-coated tablets
EU/1/06/342/01
Sorafenib (as tosylate) Bayer AG โ€”
Nexium 10 mg granules for gastro-resistant oral suspension in sachet
PA2242/013/001
Esomeprazole Grunenthal Pharma Limited. Not marketed
Nexium 20 mg gastro-resistant tablets
PA2242/013/002
Esomeprazole magnesium trihydrate Grunenthal Pharma Limited. Marketed
Nexium 20 mg gastro-resistant tablets
PPA0465/083/001
Esomeprazole PCO Manufacturing Ltd. โ€”
โ† 1 2 3 4 5 6 โ†’

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.